Status Report on Antibiotic Resistance: Implications for the Dermatologist

Dermatologic Clinics

Volumn 25, Issue 2, 2007, Pages 127-132

  Del Rosso, James Q ^a   Leyden, James J ^b  

^a VALLEY HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFDINIR; CEPHALOSPORIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; LINCOSAMIDE; MACROLIDE; MINOCYCLINE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ACNE VULGARIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL SKIN DISEASE; DRUG MECHANISM; DRUG POTENCY; GENERAL PRACTITIONER; GENETIC VARIABILITY; HUMAN; MEDICAL EDUCATION; MONOTHERAPY; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; DERMATITIS; DERMATOLOGY; DRUG RESISTANCE, BACTERIAL; HUMANS; PRACTICE GUIDELINES;

EID: 34147167179     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.01.001     Document Type: Review

References (39)

1. Del Rosso J.Q. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis 66 Suppl (2000) 7-13
2. Del Rosso JQ, Elston DM, Hirschmann J, et al. Summary report from the Scientific Panel on antibiotic use in dermatology: usage patterns, management challenges recommendations (poster presentation). American Academy of Dermatology Summer Meeting, San Diego, CA, July 26-30, 2006.
3. Kunin C.M. Resistance to antimicrobial drugs-a worldwide calamity. Ann Intern Med 118 (1993) 557-561
4. Espersen F. Resistance to antibiotics used in dermatological practice. Br J Dermatol 139 (1998) 4-8
5. Levy S.B. The challenge of antibiotic resistance. Sci Am 278 (1998) 46-53
6. Eady A.H., Cove J.H., and Layton A.M. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers. Am J Clin Dermatol 12 (2003) 813-831
7. Guay D.R.P. Treatment of bacterial skin and skin structure infections. Expert Opin Pharmacother 4 (2003) 1259-1275
8. Finkelstein J.A., Stille C., Nordin J., et al. Reduction in antibiotic use among US children 1996-2000. Pediatrics 139 (2003) 467-471
9. FDA to require warning labels on antibiotics. Health Care Business Daily. February 6, 2003.
10. Gold H.S., and Moellering Jr. R.C. Antimicrobial drug resistance. N Engl J Med 335 (1996) 1445-1453
11. Opal S.M., Mayer K.H., and Medeiros A.A. Mechanisms of bacterial antibiotic resistance. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious disease. 5th edition (2000), Churchill-Livingstone, Philadelphia 236-251
12. Medeiros A.A. Evolution and dissemination of beta-lactamase accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 24 (1997) S19-S45
13. Timmis K.N., Gonzalez-Carrero M.I., Sekizaki T., et al. Biological activities specified by antibiotic resistance plasmids. J Antimicrob Chemother 18 Suppl C (1986) 1-12
14. O'Brien T., Pla M.P., Mayer K.H., et al. Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid. Science 230 (1985) 87-88
15. Brisson-Noel A., Arthur M., and Courvalin P. Evidence for natural gene transfer from gram-positive cocci to Escherichia coli. J Bacteriol 170 (1988) 1739-1745
16. Courvalin P., Carlier C., and Collatz E. Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci. J Bacteriol 143 (1980) 541-551
17. Zscheck K.K., Hull R., Murray B.E., et al. Restriction mapping and hybridization studies of a beta-lactamase-encoding fragment from Streptococcus (Enterococcus) faecalis. Antimicrob Agents Chemother 32 (1988) 768-769
18. Leyden J.J. The evolving role of Propionibacterium acnes in acne. Semin Cutan Med Surg 20 (2001) 139-143
19. Cooper A.J. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust 169 (1998) 259-261
20. Ross J.I., Snelling A.M., Carnegie E., et al. Antibiotic resistant acne: lessons from Europe. Br J Dermatol 148 (2003) 467-478
21. Kligman A. Comparison of topical benzoyl peroxide gel, oral minocycline, oral doxycycline and a combination for suppression of P acnes in acne patients. J Dermatolog Treat 9 (1998) 187-191
22. Ross J.I., Snelling A.M., Eady E.A., et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol 144 (2001) 339-346
23. Eady E.A., Bojar R.A., Jones C.E., et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 134 (1996) 107-113
24. Leyden J.J., McGinley K.J., Cavalieri S., et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 8 (1983) 41-45
25. Miller Y.W., Eady E.A., Lacey R.W., et al. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 38 (1996) 829-837
26. Marples R.R., and Kligman A.M. Ecological effect of oral antibiotics on the microflora of human skin. Arch Dermatol 103 (1971) 148-153
27. Adams S.J., Cunliffe W.J., and Cooke E.M. Long-term antibiotic therapy for acne vulgaris: effects on the bowel flora of patients and their relatives. J Invest Dermatol 85 (1985) 35-37
28. Levy R.M., Huang E.Y., Roling D., et al. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 139 (2003) 467-471
29. Eady E.A. Bacterial resistance in acne. Dermatology 196 (1998) 59-66
30. Cheesbrough M.J. Antibiotics should not be first treatment for acne. [letter]. BMJ 318 (1999) 669
31. Hayden G.F. Skin diseases encountered in a pediatric clinic: a one-year prospective study. Am J Dis Child 139 (1985) 36-38
32. Finerty EF, Polan DW Jr. Changing antibiotic sensitivities of bacterial skin diseases: office practices. Cutis 1979;23:227-30.
33. Nishijima S., and Kurakowa I. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections. Int J Antimicrob Agents 19 (2002) 241-243
34. Moy J.A., Caldwell-Brown D., Lin A.N., et al. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa. J Am Acad Dermatol 22 (1990) 893-895
35. Cohen P.R., and Grossman M.E. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. J Am Acad Dermatol 51 (2004) 132-135
36. Eliopoulos G.M. Mechanisms of bacterial resistance to antimicrobial drugs. In: Gorbach S.L., Bartlett J.G., and Blacklow N.R. (Eds). Infectious diseases. 2nd edition (1998), WB Saunders, Philadelphia 319-330
37. Del Rosso J.Q. Cephalosporin antibiotics. Dis Mon 50 (2004) 315-331
38. Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40 mg doxycycline, USP capsules) administered once daily treatment for rosacea. J Am Acad Dermatol 2004, accepted for publication.
39. Skidmore R.S., Kovack R., Walker C., et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 139 (2003) 459-464